A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)

NCT00304551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cirrhosis
Chronic Hepatitis C

Interventions

DRUG: peginterferon alfa-2a 180μg
DRUG: peginterferon alfa-2a 90μg
DRUG: ribavirin

Sponsor

Chugai Pharmaceutical